University of Crete (UOC)
Η επίδραση της ενδοϋαλοειδικής έγχυσης Bevacizumab (1.25mg) στην αντιμετώπιση της εξιδρωματικού τύπου ηλικιακής εκφύλισης της ωχράς κηλίδας σαν μονοθεραπεία και σε συνδυασμό με τη φωτοδυναμική θεραπεία χαμηλής ενέργειας
Abstract
dc:descriptionPurpose: To evaluate combination treatment with reduced-fluence photodynamic therapy (RDPDT) withVerteporfin and intravitreal bevacizumab, compared to bevacizumab alone, for choroidal neovascularization(CNV) in age-related macular degeneration. Methods: This was a prospective, randomized comparative studycomprising 95 patients with CNV. 49 patients received RDPDT (25 J/cm2) followed by intravitreal bevacizumab1.25mg one hour later, while 46 received intravitreal bevacizumab alone. Patients were followed for 12 monthsat four-week intervals with visual acuity (VA) assessment and Optical Coherence Tomography (OCT) of themacula. Bevacizumab re-injections were performed as needed. Results: On average, patients were re-injected4.45 times in the combination group and 6.96 times in the bavacizumab group (p50.001). At 12 months, VAimproved by 8.64 letters in the bevacizumab group and by 8.37 letters in the combination group (p = 0.922).Conclusion: Adding a reduced-fluence PDT arm in combination with bevacizumab offers similar results to thoseof intravitreal bevacizumab alone with significantly reduced number of injection repetitions.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Datseris, Ioannis
- Δατσέρης, Ιωάννης
Subjects
dc:subject × 12Rights
dc:rights- Statement dc:rights
-
- BY
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/35164